Voglibose tablet and preparation method thereof

A technology for voglibose and sugar tablets, applied in the field of voglibose tablets and their preparation, can solve the problems of inability to meet huge demand, few manufacturers, etc., and achieves reduction of labor intensity of workers, low production cost, and convenience Easy to operate effect

Active Publication Date: 2013-04-03
SHIJIAZHUANG HUAXIN PHARMA
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] This product has unique advantages in lowering blood sugar and has a broad market prospect. At the same time, there are few domestic manufacturers, which cannot meet the huge demand for

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Voglibose tablet and preparation method thereof
  • Voglibose tablet and preparation method thereof
  • Voglibose tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] prescription:

[0025]

[0026] Preparation:

[0027] (1) Pass the voglibose through a 80-mesh sieve, and pass the filler and lubricant through a 100-mesh sieve for later use.

[0028] (2) Weigh the prescribed amount of voglibose and the filling agent and mix them uniformly by incremental method. Mix the prescribed amount of voglibose with 1% (0.275g) of the prescribed amount of the filling agent (starch) first, Then add 4% (1.1g) of the prescription amount of filler (starch) and mix evenly, then add 10% (2.75g) of the prescription amount of filler (starch) and mix evenly, then add 15% of the prescription amount of filler (starch) (4.125g) mixed well and finally the blended mixture was mixed well with the remaining filler (remaining starch (19.525g) and 100% lactose).

[0029] (3) Add an appropriate amount of binder to make soft materials, granulate with a 20-mesh sieve, dry, pass through a 18-mesh sieve for granulation and set aside.

[0030] (4) Add the prescrib...

Embodiment 2

[0032] prescription:

[0033]

[0034] Preparation:

[0035] (1) Pass the voglibose through a 80-mesh sieve, and pass the filler and lubricant through a 100-mesh sieve for later use.

[0036] (2) Weigh the prescribed amount of voglibose and fillers and mix them evenly by equal volume addition method.

[0037] (3) Add an appropriate amount of binder to make soft materials, granulate with a 20-mesh sieve, dry, pass through a 18-mesh sieve for granulation and set aside.

[0038] (4) Add the prescribed amount of lubricant to the granules, mix for 15 minutes, and press into tablets to obtain the finished product.

Embodiment 3

[0040] prescription:

[0041]

[0042] Preparation:

[0043] (1) Pass the voglibose through a 80-mesh sieve, and pass the filler and lubricant through a 100-mesh sieve for later use.

[0044] (2) Weigh the prescribed amount of voglibose and fillers and mix them evenly by equal volume addition method.

[0045] (3) Add an appropriate amount of binder to make soft materials, granulate with a 20-mesh sieve, dry, pass through a 18-mesh sieve for granulation and set aside.

[0046] (4) Add the prescribed amount of lubricant to the granules, mix for 15 minutes, and press into tablets to obtain the finished product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides an oral hypoglycemic drug, namely voglibose tablet and a preparation method thereof. The tablet comprises the following components in parts by weight: 1 part of voglibose, 400-800 parts of filler, 30-150 parts of adhesive, 2-20 parts of lubricant and the like. The preparation method comprises the following steps of firstly screening the original auxiliary materials, then mixing the screened material evenly, adding a certain amount of adhesive for preparing a soft material, adding lubricant after pelletizing and size stabilization, mixing uniformly and tabletting. The stability of the voglibose tablet in storage process is improved, so that a patient can take the tablet more safely and effectively, furthermore, production verification test shows that the preparation technology has the characteristics of being scientific and reasonable, simple and easy to operate, lower in manufacture cost, and the like.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to a voglibose tablet and a preparation method thereof which have undergone technological research and verification. Background technique [0002] Voglibose Tablets (trade name: Basen) is a new generation of α-glucosidase inhibitors developed by Takeda Pharmaceutical Co., Ltd. in Japan. It was first launched in Japan in 1994 under the trade name Basen and in Korea in 1998. It was launched in China in 1999. The domestic manufacturer is mainly Tianjin Takeda, and the trade name is "Bexin". In addition, this product and pioglitazone (pioglitazone) form a compound to improve glucose tolerance, which is undergoing phase III clinical trials in Japan, and is suitable for lowering blood sugar after meals. Preclinical and clinical studies have shown that the pharmacological effect of the drug is to inhibit the disaccharide hydrolase in the small intestine by competitively inhibiting the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/20A61K31/133A61P3/10
Inventor 张硕王敏马海波李明海张云郭卿
Owner SHIJIAZHUANG HUAXIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products